NO20013753L - Anvendelse av moxonidin til behandling etter hjerteinfarkt - Google Patents

Anvendelse av moxonidin til behandling etter hjerteinfarkt

Info

Publication number
NO20013753L
NO20013753L NO20013753A NO20013753A NO20013753L NO 20013753 L NO20013753 L NO 20013753L NO 20013753 A NO20013753 A NO 20013753A NO 20013753 A NO20013753 A NO 20013753A NO 20013753 L NO20013753 L NO 20013753L
Authority
NO
Norway
Prior art keywords
moxonidine
myocardial infarction
infarction
myocardial
physiologically compatible
Prior art date
Application number
NO20013753A
Other languages
English (en)
Other versions
NO321061B1 (no
NO20013753D0 (no
Inventor
Regina Geertruida Schoemaker
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO20013753D0 publication Critical patent/NO20013753D0/no
Publication of NO20013753L publication Critical patent/NO20013753L/no
Publication of NO321061B1 publication Critical patent/NO321061B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
NO20013753A 1999-02-01 2001-07-31 Anvendelse av moksonidin til fremstilling av legemidler for behandling etter hjerteinfarkt NO321061B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19903780 1999-02-01
PCT/EP2000/000655 WO2000045820A1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt

Publications (3)

Publication Number Publication Date
NO20013753D0 NO20013753D0 (no) 2001-07-31
NO20013753L true NO20013753L (no) 2001-09-28
NO321061B1 NO321061B1 (no) 2006-03-06

Family

ID=7895940

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013753A NO321061B1 (no) 1999-02-01 2001-07-31 Anvendelse av moksonidin til fremstilling av legemidler for behandling etter hjerteinfarkt

Country Status (26)

Country Link
US (1) US7041303B2 (no)
EP (1) EP1150680B1 (no)
JP (1) JP4686027B2 (no)
KR (1) KR20010092793A (no)
CN (1) CN1166363C (no)
AT (1) ATE286731T1 (no)
AU (1) AU774855B2 (no)
BR (1) BR0007894A (no)
CA (1) CA2361600C (no)
CZ (1) CZ20012615A3 (no)
DE (2) DE10003771A1 (no)
DK (1) DK1150680T3 (no)
ES (1) ES2235829T3 (no)
HK (1) HK1042650B (no)
HU (1) HUP0105210A3 (no)
IL (1) IL144621A (no)
NO (1) NO321061B1 (no)
NZ (1) NZ513869A (no)
PL (1) PL195124B1 (no)
PT (1) PT1150680E (no)
RU (1) RU2261097C2 (no)
SK (1) SK10082001A3 (no)
TR (1) TR200102221T2 (no)
UA (1) UA67822C2 (no)
WO (1) WO2000045820A1 (no)
ZA (1) ZA200105827B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850331B (zh) * 2012-09-17 2015-05-20 符爱清 一种化合物的制备方法
CN103483268B (zh) * 2013-09-17 2015-10-14 常州大学 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
PL330637A1 (en) * 1996-06-06 1999-05-24 Lilly Co Eli Agent for and method of treating hypostatic cardiac insufficiency

Also Published As

Publication number Publication date
AU774855B2 (en) 2004-07-08
PT1150680E (pt) 2005-03-31
UA67822C2 (uk) 2004-07-15
NO321061B1 (no) 2006-03-06
IL144621A0 (en) 2002-05-23
TR200102221T2 (tr) 2002-01-21
JP4686027B2 (ja) 2011-05-18
CZ20012615A3 (cs) 2002-01-16
CA2361600A1 (en) 2000-08-10
BR0007894A (pt) 2001-10-30
JP2002536334A (ja) 2002-10-29
RU2261097C2 (ru) 2005-09-27
WO2000045820A1 (de) 2000-08-10
DE50009220D1 (de) 2005-02-17
PL195124B1 (pl) 2007-08-31
HUP0105210A3 (en) 2003-01-28
US7041303B2 (en) 2006-05-09
HK1042650B (zh) 2005-05-06
ATE286731T1 (de) 2005-01-15
CN1338938A (zh) 2002-03-06
ZA200105827B (en) 2002-07-16
AU2440400A (en) 2000-08-25
IL144621A (en) 2004-12-15
ES2235829T3 (es) 2005-07-16
EP1150680B1 (de) 2005-01-12
HK1042650A1 (en) 2002-08-23
CA2361600C (en) 2008-08-26
DE10003771A1 (de) 2000-08-03
SK10082001A3 (sk) 2002-04-04
PL350559A1 (en) 2002-12-16
NZ513869A (en) 2001-09-28
HUP0105210A2 (hu) 2002-05-29
US20020045633A1 (en) 2002-04-18
KR20010092793A (ko) 2001-10-26
NO20013753D0 (no) 2001-07-31
EP1150680A1 (de) 2001-11-07
DK1150680T3 (da) 2005-03-07
CN1166363C (zh) 2004-09-15

Similar Documents

Publication Publication Date Title
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
WO2001012122A3 (en) Method and system for treating cardiac arrest using hypothermia
SE9600071D0 (sv) New oral formulation of two active ingredients I
EP1564210A4 (en) 4-OXOQUINOLINIC COMPOUNDS AND THEIR USE AS INHIBITORS OF HIV-INTEGRASE
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
SG156681A1 (en) Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
NO20013753L (no) Anvendelse av moxonidin til behandling etter hjerteinfarkt
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
ES2191206T3 (es) Nueva utilizacion de la creatina.
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
HUP9801894A2 (hu) Dofetilid alkalmazása kongesztív szívpanaszok kezelésére szolgáló gyógyszerkészítmények előállítására
RU2005129591A (ru) Способ лечения хронической сердечной недостаточности
CA2238920A1 (en) Nephroprotective pharmaceutical composition and use thereof
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
RU2002116408A (ru) Способ реперфузионной терапии больных острым инфарктом миокарда
DE60235965D1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
RU2000103385A (ru) Способ лечения острого панкреотита
DK1019066T3 (da) Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand